~~<i id='855E1D6796'><strike id='855E1D6796'><tt id='855E1D6796'><pre id='855E1D6796'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

comprehensive

author：fashion 2025-10-02 11:08:04 - browse：7866

A European regulatory panel has recommended against approval of a lung cancer drug made by Mirati Therapeutics, the company said Friday.

Mirati said it will appeal the negative opinion of the drug, called Krazati, issued by a committee of the European Medicines Agency that met this week. But for now, the adverse decision is likely to be adopted by European regulators and prevent the company from marketing the pill in Europe.

Krazati works by blocking a specific type of KRAS alteration called G12C, found in approximately 13% of lung tumors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Bristol 'take

leisure time

Wikipedia

hotspot

leisure time

explore

leisure time

Stainingrevealsdifferentimmunecellsinahealthyhumancolon.CourtesyOliviaNewton-JohnCancerResearchinsti

WSS

Why Charlie Gard's case is so disturbing to Americans

Was Amgen transparent enough on FDA's concern on cancer drug?

What to expect at HLTH 2023, the health care industry conference

FDA panel signals lack of confidence in Amgen cancer drug data

Digital health funding stays low as a new reality sets in

Companies helping big Covid

knowledge

comprehensive

leisure time

Medicare details structure of new drug price negotiation program

FDA panel signals lack of confidence in Amgen cancer drug data

Novavax promises a turnaround & Lilly roils the obesity market

Was Amgen transparent enough on FDA's concern on cancer drug?

Drug repurposing or repositioning? The language matters

After half a century, Israel moves to evict squatter from his cave home on the beach

Apple is now the first public company to be valued at $3 trillion

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

Apple is now the first public company to be valued at $3 trillion

Analysis of telehealth claims data suggest service duplication

Wikipedia

AI can decode, harness the power of the humane immune system

Watch the official trailer for 'Ahsoka' series

Antibody drugs appear effective. Now can we make enough of them?

AI can decode, harness the power of the humane immune system

FDA rejects Alnylam's heart disease treatment over insufficient data

A Q&A with the global head of Boehringer Ingelheim's innovation unit

hotspot

leisure time

explore

leisure time